Preynat-Seauve Olivier, Villiers Christian L, Jourdan Guillaume, Richard Marie-Jeanne, Plumas Joël, Favier Alain, Marche Patrice N, Favrot Marie-Christine
Unité Mixte de Thérapie Cellulaire et Tissulaire et Unité de Cancérologie Biologique et Biothérapies, CHU, Grenoble, France.
Eur J Immunol. 2004 Jan;34(1):147-55. doi: 10.1002/eji.200324260.
The receptor for the iC3b fragment of complement, CR3, is involved in monocytes/macrophages and neutrophils phagocytosis. CR3 is known to interact with the low affinity receptor for Ig (CD16) and previous studies have suggested that this cooperation modulates CR3 functions. Herein we have studied the effect of CD16 on the ability of human monocytes CR3 to bind to iC3b. We show that iC3b binding to CR3 is inhibited by several reagents that are known to dissociate the CD16/CR3 complex. In addition, treatment of monocytes with soluble CD16 inhibited iC3b binding to CR3. Together, these data indicate that iC3b binding to monocyte CR3 is up-regulated by an interaction between membrane CD16 and CR3. The implication of CD16 in CR3 binding to iC3b was also analyzed after monocyte differentiation into dendritic cells (DC). Differentiation of monocytes into DC abrogates the cooperation between CD16 and CR3, due to a loss of CD16/CR3 interaction. In accordance, this phenomenon is associated with a lack of iC3b binding to DC. As a consequence, deposition of iC3b on apoptotic cells does not modify their phagocytosis by DC. In conclusion, we demonstrate a cooperation between CD16 and CR3 that favors iC3b binding to CR3 but is lost on DC.
补体iC3b片段的受体CR3参与单核细胞/巨噬细胞和中性粒细胞的吞噬作用。已知CR3与Ig低亲和力受体(CD16)相互作用,先前的研究表明这种协同作用可调节CR3的功能。在此,我们研究了CD16对人单核细胞CR3结合iC3b能力的影响。我们发现,已知能使CD16/CR3复合物解离的几种试剂可抑制iC3b与CR3的结合。此外,用可溶性CD16处理单核细胞可抑制iC3b与CR3的结合。这些数据共同表明,膜CD16与CR3之间的相互作用上调了iC3b与单核细胞CR3的结合。在单核细胞分化为树突状细胞(DC)后,也分析了CD16在CR3与iC3b结合中的作用。单核细胞向DC的分化消除了CD16与CR3之间的协同作用,这是由于CD16/CR3相互作用的丧失。相应地,这种现象与DC缺乏iC3b结合相关。因此,iC3b在凋亡细胞上的沉积不会改变DC对它们的吞噬作用。总之,我们证明了CD16与CR3之间的协同作用有利于iC3b与CR3的结合,但在DC上这种作用消失。